FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup
Identificadores
Identificadores
Data de publicación
2012Título da revista
JOURNAL OF RHEUMATOLOGY
Tipo de contido
Artigo